Tza-Huei Jeff Wang

Works at

Sources: reporter.nih.gov

Grants and prizes

  • National Cancer Institute

    U2C, Optimizing Ultrasensitive DNA methylation detection for lung cancer and other malignancies, U2CCA271885, 2022–2027, 26 Aug 2026

  • National Cancer Institute

    R01, Development of a low-cost epigenetic screening assay for Pap specimen-based detection of early-stage ovarian cancer in high-risk women, R01CA260628, 2021–2027, 19 May 2025

  • National Cancer Institute

    R33, A low-cost, multiplexed digital high resolution melt platform for DNA methylation-based detection and identification of cancers in liquid biopsies, R33CA272321, 2022–2026, 22 Aug 2024

Sources: reporter.nih.gov